Sun Pharma makes an offer to buy Taro’s remaining stock
In the latest move taken by the pharmaceutical brand, Sun Pharma on May 27, has offered to acquire the shares it doesn’t already own in Taro Pharmaceutical Industries, in which it is a majority shareholder, for USD 38 apiece. Currently, Sun Pharma owns a 78.48 percent of sta...
